Health and medicine

HRT and heart disease

Claim not established

Treatment guidance evolved; original government recommendation for heart disease prevention is not established.

Fact-check

HRT warnings and NICE 2015 guidance documented; no verified official government recommendation to use HRT to prevent heart disease.

The evidence

Links go to the original records: Hansard, legislation, official guidance and news reports. A before-and-after pair is not always proof of a direct contradiction, so read the originals for exact wording.

After: what changed

NICE menopause guideline NG23 (opens in new tab)
NICE — Symptom treatment, not universal cardiovascular prevention

Context

Ministerial answer, March 2004 (opens in new tab)
Hansard — States HRT not licensed for prevention of heart disease

What the source documents claim

These are summaries from the original documents behind this archive. They have not been checked word for word. Where they differ from the fact-check above, the fact-check is the more reliable account.

Hormone Replacement Therapy (HRT) Guidelines (1990s–2015)

Document A, case 07

Original advice: In the 1990s, NHS guidance promoted long-term HRT not only for menopause symptoms but also as a preventative measure against heart disease and osteoporosis.
How it was framed: Department of Health prescribing bulletins cited large observational cohort studies indicating significant cardiovascular protection for postmenopausal women.
Later change: Following the 2002 Women's Health Initiative trial, the UK Committee on Safety of Medicines issued urgent warnings sharply restricting HRT due to breast cancer and stroke risks—before NICE reversed course again in 2015, re-establishing HRT as the safe first-line treatment.